Exhalation Delivery System with Fluticasone in Chronic Rhinosinusitis by Eosinophil, Asthma, and Allergy Status

Study limitation reported by the research below: “Dose-specific subgroup results are not reported separately; pooled EDS-FLU doses (186 µg and 372 µg) are combined in the abstract's subgroup comparisons.”